Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) encompasses chronic conditions like Crohn's disease and ulcerative colitis, in which the immune system mounts a dysregulated response against the gut, causing persistent inflammation and tissue damage. Genetic studies have identified hundreds of susceptibility loci that implicate pathways in immune signaling, intestinal barrier function, and the body's interactions with its microbial residents, helping to explain why some individuals develop IBD while others do not. Despite this progress, the precise mechanisms linking genetic variation to disease onset and severity remain incompletely understood, as do the reasons why IBD incidence has risen sharply in newly industrialized countries over recent decades. Current research is focused on translating these genetic and immunological insights into more targeted therapies that can achieve sustained remission rather than merely managing symptoms.
- Works
- 123,282
- Total citations
- 2,295,932
- Keywords
- Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative ColitisGeneticsImmunologyTherapies
Top papers in Inflammatory Bowel Disease
Ordered by total citation count.
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies↗ 5,917
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease↗ 5,583
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease↗ 5,014OA
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease↗ 4,851OA
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review↗ 4,815
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases↗ 4,688
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases↗ 4,579OA
- Unravelling the pathogenesis of inflammatory bowel disease↗ 4,331
- <i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients↗ 4,320OA
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial↗ 4,162
- Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis↗ 3,880OA
- Ulcerative colitis↗ 3,433OA
Active researchers
Top authors in this area, ranked by h-index.